Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2026 08:00 ET | Source: Meyer Wilson Werning

Meyer Wilson Werning Secures $2.3 Million Arbitration Award for Eleven Families in Investment Advisory Breach of Fiduciary Duty Case

Columbus, Ohio, March 09, 2026 (GLOBE NEWSWIRE) -- Meyer Wilson Werning is proud to announce a significant victory on behalf of eleven Ohio families in a securities arbitration case against an Ohio...
March 09, 2026 06:39 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 9 March 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
March 03, 2026 09:00 ET | Source: BiggerPockets

BiggerPockets Unlocks Institutional-Grade Pricing Power for Everyday Investors with Pro Perks Membership Expansion

DENVER, March 03, 2026 (GLOBE NEWSWIRE) -- BiggerPockets, the premier community and resource hub for real estate investors (REIs), today announced the addition of exclusive financing and insurance...
March 02, 2026 10:55 ET | Source: Novo Nordisk A/S

Election of employee representatives to the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 2 March 2026 – The employees in Novo Nordisk A/S have completed the election of employee representatives to the Board of Directors of Novo Nordisk A/S. The following employee...
March 02, 2026 06:22 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 2 March 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
March 02, 2026 04:00 ET | Source: Novo Nordisk A/S

Novo Nordisk announces more than 400 million euro expansion in its manufacturing facility in Athlone, Ireland

The investment will support the upgrade and retrofit of the existing facility and enhance Novo Nordisk’s capacity to manufacture oral GLP-1s outside the US
February 26, 2026 01:00 ET | Source: Clariant International Ltd

Clariant delivers third year of strong EBITDA margin improvement – EBITDA margin before exceptional items up 180 basis points versus prior year to 17.8 %

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR FOURTH QUARTER / FULL YEAR | 2025 Q4 2025 sales increased by 1 % in local currencies1 to CHF 1.028 billion due to strong volume growth in Catalysts and...
February 25, 2026 08:00 ET | Source: Novo Nordisk A/S

Novo Nordisk and Vivtex partner to develop next-generation oral medicines for obesity and diabetes

Novo Nordisk and Vivtex Corp announced partnership to develop next-generation oral biologic medicines for obesity, diabetes + associated comorbidities
February 24, 2026 03:39 ET | Source: Novo Nordisk A/S

Novo Nordisk: Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China

The United Laboratories International Holdings Limited and Novo Nordisk today announced topline results from a Chinese phase 2 trial of UBT251
February 23, 2026 07:24 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 23 February 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...